Case Reports of Acute Transverse Myelitis Associated With mRNA Vaccine for COVID-19.
Hyunjong EomSeung Woo KimMinkyoung KimYe Eun KimJi Hyun KimHa Young ShinHye Lim LeePublished in: Journal of Korean medical science (2022)
Acute transverse myelitis (ATM) has been reported as rare complication of vaccination. Herein, we report 2 cases of ATM after the administration of an mRNA vaccine for coronavirus disease 2019 (COVID-19). The first one is an 81-year-old man who received the BNT162b2 vaccine. He presented with bilateral hand weakness. Spine magnetic resonance imaging (MRI) showed high signal intensity from the C1 to C3 vertebrae. The second is a 23-year-old woman who received the BNT162b2 vaccine and experienced tingling in her legs. Spine MRI showed a high signal intensity lesion at the conus medullaris. These patients were treated with intravenous methylprednisolone and their symptoms improved slightly. Careful follow-up is needed to identify adverse events after the administration of mRNA vaccines for COVID-19.
Keyphrases
- coronavirus disease
- magnetic resonance imaging
- sars cov
- contrast enhanced
- liver failure
- respiratory syndrome coronavirus
- end stage renal disease
- newly diagnosed
- dna damage
- respiratory failure
- high dose
- binding protein
- high intensity
- chronic kidney disease
- computed tomography
- ejection fraction
- diffusion weighted imaging
- prognostic factors
- case report
- peritoneal dialysis
- aortic dissection
- patient reported outcomes
- intensive care unit
- physical activity
- mechanical ventilation
- sleep quality